Ekso Bionics (NASDAQ:EKSO) Shares Pass Below 50 Day Moving Average – Time to Sell?

Shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.81 and traded as low as $0.58. Ekso Bionics shares last traded at $0.58, with a volume of 131,580 shares.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on EKSO shares. HC Wainwright reduced their price objective on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th. StockNews.com began coverage on Ekso Bionics in a report on Saturday. They issued a “hold” rating on the stock. Finally, Lake Street Capital decreased their price target on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th.

Ekso Bionics Trading Down 10.2 %

The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. The firm has a 50 day moving average price of $0.80 and a 200 day moving average price of $1.00. The stock has a market capitalization of $12.76 million, a PE ratio of -0.89 and a beta of 1.43.

Ekso Bionics (NASDAQ:EKSO) last issued its quarterly earnings data on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.02). The company had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. During the same quarter last year, the business posted ($0.24) earnings per share. Equities analysts expect that Ekso Bionics Holdings, Inc. will post -0.48 EPS for the current fiscal year.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.